Skip to content

Total Liabilities at other companies

Abbott logo
AbbottABT
$4.67B
Johnson & Johnson logo
Johnson & JohnsonJNJ
$119.71B+3.6%
AtriCure logo
AtriCureATRC
$152.3M+11.2%
Medtronic logo
MedtronicMDT
$42.96B-1.1%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$1.09B+5.1%
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s total liabilities?
Pulse Biosciences, Inc. (PLSE) reported total liabilities of $15.32M in Q1 2026.
How has Pulse Biosciences, Inc.'s total liabilities changed year-over-year?
Pulse Biosciences, Inc.'s total liabilities increased by 2.6% year-over-year, from $14.93M to $15.32M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.